Nanobiotix S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by Nanobiotix S.A. for the month of September 2026. The filing, dated September 9, 2026, serves to incorporate by reference a press release issued on the same date (Exhibit 99.1). The registrant files annual reports under Form 20-F.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a conduit for a press release rather than a financial statement containing quantitative data.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. The content is limited to the notification of the press release issuance.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. These details are contained within the attached press release (Exhibit 99.1), the text of which is not included in the provided input.
Investor Verification Checklist
- Review the full text of the press release dated September 9, 2026 (Exhibit 99.1) for specific operational updates.
- Verify the nature of the announcement, as the Form 6-K itself contains no substantive business details.
- Confirm the filing status and signature authorization by Bart Van Rhijn, Chief Financial Officer.